NM_001374353.1:c.4281G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374353.1(GLI2):​c.4281G>A​(p.Met1427Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00384 in 1,613,706 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0047 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 79 hom. )

Consequence

GLI2
NM_001374353.1 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.35

Publications

10 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Illumina
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002585888).
BP6
Variant 2-120990246-G-A is Benign according to our data. Variant chr2-120990246-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 194230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0505 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374353.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLI2
NM_001374353.1
MANE Select
c.4281G>Ap.Met1427Ile
missense
Exon 14 of 14NP_001361282.1A0A7I2PJA1
GLI2
NM_001371271.1
c.4332G>Ap.Met1444Ile
missense
Exon 14 of 14NP_001358200.1P10070-5
GLI2
NM_005270.5
c.4332G>Ap.Met1444Ile
missense
Exon 14 of 14NP_005261.2P10070-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLI2
ENST00000361492.9
TSL:1 MANE Select
c.4281G>Ap.Met1427Ile
missense
Exon 14 of 14ENSP00000354586.5A0A7I2PJA1
GLI2
ENST00000452319.6
TSL:5
c.4332G>Ap.Met1444Ile
missense
Exon 13 of 13ENSP00000390436.1P10070-5
GLI2
ENST00000934404.1
c.4275G>Ap.Met1425Ile
missense
Exon 14 of 14ENSP00000604463.1

Frequencies

GnomAD3 genomes
AF:
0.00472
AC:
719
AN:
152200
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000820
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00537
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00266
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00970
AC:
2435
AN:
251078
AF XY:
0.00775
show subpopulations
Gnomad AFR exome
AF:
0.000616
Gnomad AMR exome
AF:
0.0545
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00633
Gnomad NFE exome
AF:
0.00245
Gnomad OTH exome
AF:
0.00898
GnomAD4 exome
AF:
0.00375
AC:
5478
AN:
1461388
Hom.:
79
Cov.:
34
AF XY:
0.00355
AC XY:
2583
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.0523
AC:
2337
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00274
AC:
236
AN:
86258
European-Finnish (FIN)
AF:
0.00733
AC:
388
AN:
52926
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00206
AC:
2291
AN:
1112006
Other (OTH)
AF:
0.00328
AC:
198
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
383
766
1149
1532
1915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00473
AC:
720
AN:
152318
Hom.:
10
Cov.:
33
AF XY:
0.00481
AC XY:
358
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000818
AC:
34
AN:
41582
American (AMR)
AF:
0.0275
AC:
421
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4832
European-Finnish (FIN)
AF:
0.00537
AC:
57
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00266
AC:
181
AN:
68014
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000967
Hom.:
3
Bravo
AF:
0.00770
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.00820
AC:
996
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00101

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
2
Holoprosencephaly 9 (2)
-
-
2
Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Uncertain
0.44
T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.15
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.4
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.032
Sift
Benign
0.048
D
Sift4G
Benign
0.42
T
Polyphen
0.013
B
Vest4
0.23
MutPred
0.29
Loss of catalytic residue at M1444 (P = 0.018)
MVP
0.33
MPC
0.36
ClinPred
0.0031
T
GERP RS
3.7
Varity_R
0.13
gMVP
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146467786; hg19: chr2-121747822; COSMIC: COSV58048319; API